Plain-English translation of NCT04080635 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing brodalumab, a medication for plaque psoriasis, to understand how much of the drug stays in your body and how well it works for you personally. Researchers will take blood samples during regular visits to measure medication levels and check for your body's immune response to the treatment. The goal is to figure out which patients benefit most from this medication and at what dose.
Psoriasis medications work differently for different people, and doctors don't have good tools yet to predict who will respond best. By measuring how much of this medication stays in your bloodstream and tracking your skin improvement, researchers hope to personalize treatment and help future patients get better results faster.
You likely qualify if…
You likely don't qualify if…
You will continue taking brodalumab at the standard dose: an initial loading dose, then weekly injections for two weeks, then one injection every two weeks. At each study visit, a nurse will draw blood to measure how much medication is in your system and check for immune reactions. A doctor will also examine your skin and ask you to complete short questionnaires about how psoriasis affects your daily life. The study involves about 100 patients total.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Belgium